Cleared Traditional

K242053 - FX CorAL 40 (F00009214) (FDA 510(k) Clearance)

Also includes:
FX CorAL 50 (F00009215)
Mar 2025
Decision
252d
Days
Class 2
Risk

K242053 is an FDA 510(k) clearance for the FX CorAL 40 (F00009214). This device is classified as a Dialyzer, High Permeability With Or Without Sealed Dialysate System (Class II - Special Controls, product code KDI).

Submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on March 21, 2025, 252 days after receiving the submission on July 12, 2024.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5860.

Submission Details

510(k) Number K242053 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2024
Decision Date March 21, 2025
Days to Decision 252 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code KDI — Dialyzer, High Permeability With Or Without Sealed Dialysate System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5860

Similar Devices — KDI Dialyzer, High Permeability With Or Without Sealed Dialysate System

All 17
ELISIO™-H
K260533 · Nipro Medical Corporation · Mar 2026
multiFlux 130 (F00013123)
K252459 · Fresenius Medical Care Renal Therapies Group, LLC · Feb 2026
FX CorAL 40
K253518 · Fresenius Medical Care Renal Therapies Group, LLC · Dec 2025
2008T HD SYS. CDX BLUESTAR (191124)
K243237 · Fresenius Medical Care Renal Therapies Group, LLC · Jun 2025
5008X Hemodialysis System
K243505 · Fresenius Medical Care Renal Therapies Group, LLC · May 2025
DHF 0.2 Hemoconcentrator (DHF 02)
K243264 · Sorin Group Italia S.R.L. · Apr 2025